Paul Joyce
Overview
Explore the profile of Paul Joyce including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
1838
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ariaee A, Koentgen S, Wardill H, Hold G, Prestidge C, Armstrong H, et al.
eGastroenterology
. 2025 Feb;
2(2):e100055.
PMID: 39944472
Inflammatory bowel disease (IBD) is characterised by chronic inflammation in the gastrointestinal tract, with unclear aetiology but with known factors contributing to the disease, including genetics, immune responses, environmental factors...
2.
Wright L, Wignall A, Subramaniam S, Schultz H, Joyce P, Prestidge C
Int J Pharm
. 2025 Jan;
670:125179.
PMID: 39778728
Decreased saliva production due to salivary gland damage can result in difficulty speaking and swallowing, significantly reducing quality of life for head and neck cancer patients receiving radiotherapy. It is...
3.
Ariaee A, Wardill H, Wignall A, Prestidge C, Joyce P
Foods
. 2025 Jan;
13(24.
PMID: 39767129
In the original publication [...].
4.
Kamath S, Sokolenko E, Collins K, Chan N, Mills N, Clark S, et al.
Pharmacol Res
. 2024 Dec;
211():107561.
PMID: 39732352
Gut microbial dysbiosis or altered gut microbial consortium, in schizophrenia suggests a pathogenic role through the gut-brain axis, influencing neuroinflammatory and neurotransmitter pathways critical to psychotic, affective, and cognitive symptoms....
5.
Taheri A, Almasri R, Wignall A, Schultz H, Elz A, Ariaee A, et al.
Drug Deliv Transl Res
. 2024 Nov;
PMID: 39614037
Abiraterone acetate, a prodrug of abiraterone, is an effective antiandrogen for treating metastatic prostate cancer. However, its poor aqueous solubility restricts oral bioavailability to under 10% in fasted conditions. Additionally,...
6.
Kamath S, Joyce P
Expert Opin Drug Metab Toxicol
. 2024 Sep;
21(1):1-4.
PMID: 39297867
No abstract available.
7.
Joyce P, Allen C, Alonso M, Ashford M, Bradbury M, Germain M, et al.
Nat Nanotechnol
. 2024 Sep;
19(11):1597-1611.
PMID: 39242807
Nanomedicines have created a paradigm shift in healthcare. Yet fundamental barriers still exist that prevent or delay the clinical translation of nanomedicines. Critical hurdles inhibiting clinical success include poor understanding...
8.
Kerstens R, Joyce P
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200203
Parkinson's Disease is the second most prevalent neurological disorder globally, and its cause is still largely unknown. Likewise, there is no cure, and existing treatments do little more than subdue...
9.
Meola T, Kamath S, Elz A, Prestidge C, Wignall A, Joyce P
Eur J Pharm Biopharm
. 2024 Aug;
203:114453.
PMID: 39134099
Increasing attention is being afforded to understanding the bidirectional relationship that exists between oral drugs and the gut microbiota. Often overlooked, however, is the impact that pharmaceutical excipients exert on...
10.
Stringer A, Hargreaves B, Amaral Mendes R, Blijlevens N, Bruno J, Joyce P, et al.
Support Care Cancer
. 2024 Jul;
32(8):558.
PMID: 39080025
Advances in the treatment of cancer have significantly improved mortality rates; however, this has come at a cost, with many treatments still limited by their toxic side effects. Mucositis in...